Clinical data | |||
---|---|---|---|
Trade names | Benzedrex, Obesin, Dristan Inhaler, and others | ||
Other names |
| ||
AHFS/Drugs.com | Monograph | ||
Pregnancy category |
| ||
Routes of administration | Medical: Intranasal (inhaler) Recreational: Oral and parenteral routes | ||
ATC code | |||
Legal status | |||
Legal status |
| ||
Pharmacokinetic data | |||
Elimination half-life | 4 ± 1.5 hours | ||
Identifiers | |||
| |||
CAS Number | |||
PubChem CID | |||
DrugBank | |||
ChemSpider | |||
UNII |
| ||
KEGG | |||
CompTox Dashboard (EPA) | |||
ECHA InfoCard | 100.002.673 | ||
Chemical and physical data | |||
Formula | C10H21N | ||
Molar mass | 155.285 g·mol−1 | ||
3D model (JSmol) | |||
Chirality | Racemic mixture | ||
| |||
| |||
(what is this?) (verify) |
Propylhexedrine, commonly sold under the brand name Benzedrex, is an alkylamine primarily utilized as a topical nasal decongestant.[1] Its main indications are relief of congestion due to colds, allergies, and allergic rhinitis.[2] Propylhexedrine was first used medically in 1949, with the release of Benzedrex by Smith, Kline & French, and it has been used, mainly within the United States, since then.[3]
Schwarez
was invoked but never defined (see the help page).